Inquirer on MSN18h
World’s first anti-depression nasal spray receives FDA approvalThe US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical ...
Hosted on MSN4d
FDA approves 'ketamine' nasal spray for depression — here's everything you need to knowA nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...
CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...
The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...
Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...
The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...
An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a ...
The Food and Drug Administration recently expanded approval for Spravato, an antidepressant nasal spray used to treat ...
HealthDay on MSN13d
FDA Approves Spravato Nasal Spray for Treatment-Resistant DepressionSpravato nasal spray is administered by the patient under the supervision ... This is due to the risks for serious adverse ...
This new treatment could help bring relief for millions of Americans struggling with depression. The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for ...
The U.S. Food and Drug Administration has approved a nasal spray that is known to help treat depression.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback